It sounds like patients have only been recruited from the Melbourne site so far, things might pickup pace when Sydney get up and running.
“The trial is overseen by Dr Susan Mathers of Calvary Health Care, Bethlehem, Statewide Progressive Neurological Disease Service, Melbourne and will include a second trial site headed by Professor Dominic Rowe of the Centre for Motor Neurone Disease Research Faculty of Medicine and Health Research at Macquarie University, Sydney.”
Ann: First Patient of Cohort 2 Dosed in MND Trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.30M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 15.5¢ | $32.40K | 206.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 37701 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 355395 | 7 |
View Market Depth
| Last trade - 15.55pm 08/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |